Live from the NIH registry
Studies recruiting near Ocala right now
Top 25 of 132 recruiting studies, sorted by proximity — each links to its official registry page
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Non-small Cell Lung Cancer, Melanoma
Phase 1
Interventional 174 participants sought
Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (22.6 mi)
· Sponsor: Boehringer Ingelheim
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Ocala, Florida (0.9 mi)
· Sponsor: American Society of Clinical Oncology
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Summit Therapeutics
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Annovis Bio Inc.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Florida Cancer Specialists — Ocala, Florida (0.9 mi)
· Sponsor: Pfizer
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: 89bio, Inc.
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Advanced Urology Institute — Oxford, Florida (18.6 mi)
· Sponsor: CG Oncology, Inc.
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Ocala Cardiovascular Research — Ocala, Florida (0.9 mi)
· Sponsor: Amgen
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — The Villages, Florida (20.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Charter Research — The Villages, Florida (20.4 mi)
· Sponsor: Boehringer Ingelheim
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
K2 Medical Research — Lady Lake, Florida (22.7 mi)
· Sponsor: Lantheus Biosciences Ltd.
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Tizona Therapeutics, Inc
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
Charter Research - Lady Lake — The Villages, Florida (20.4 mi)
· Sponsor: Celgene
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Phase 3
Interventional 426 participants sought
Local Institution - 1608 — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Obesity, Overweight
Phase 2
Interventional 1,481 participants sought
Charter Research - Lady Lake — The Villages, Florida (20.4 mi)
· Sponsor: Eli Lilly and Company
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Ocala Oncology Center PL - 1102 — Ocala, Florida (0.9 mi)
· Sponsor: OncoC4, Inc.
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 540 participants sought
Nature Coast Clinical Research - Inverness /ID# 265874 — Inverness, Florida (26.0 mi)
· Sponsor: AbbVie
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease
Phase 2
Interventional 240 participants sought
Nature Coast Clinical Research - Inverness — Inverness, Florida (26.0 mi)
· Sponsor: Calico Life Sciences LLC
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.0 mi)
· Sponsor: Janssen Research & Development, LLC
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Parkinson Disease
Phase 2
Interventional 56 participants sought
Charter Research — The Villages, Florida (20.4 mi)
· Sponsor: Gateway Institute for Brain Research
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Cognitive Dysfunction, Lewy Body Disease
Phase 2
Interventional 350 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company